Literature DB >> 22262600

A systematic review of validated methods for identifying atrial fibrillation using administrative data.

Paul N Jensen1, Karin Johnson, James Floyd, Susan R Heckbert, Ryan Carnahan, Sascha Dublin.   

Abstract

PURPOSE: The objectives of this study were to characterize the validity of algorithms to identify AF from electronic health data through a systematic review of the literature and to identify gaps needing further research.
METHODS: Two reviewers examined publications during 1997-2008 that identified patients with atrial fibrillation (AF) from electronic health data and provided validation information. We abstracted information including algorithm sensitivity, specificity, and positive predictive value (PPV).
RESULTS: We reviewed 544 abstracts and 281 full-text articles, of which 18 provided validation information from 16 unique studies. Most used data from before 2000, and 10 of 16 used only inpatient data. Three studies incorporated electronic ECG data for case identification or validation. A large proportion of prevalent AF cases identified by ICD-9 code 427.31 were valid (PPV 70%-96%, median 89%). Seven studies reported algorithm sensitivity (range, 57%-95%, median 79%). One study validated an algorithm for incident AF and reported a PPV of 77%.
CONCLUSIONS: The ICD-9 code 427.31 performed relatively well, but conclusions about algorithm validity are hindered by few recent data, use of nonrepresentative populations, and a disproportionate focus on inpatient data. An optimal contemporary algorithm would likely draw on inpatient and outpatient codes and electronic ECG data. Additional research is needed in representative, contemporary populations regarding algorithms that identify incident AF and incorporate electronic ECG data.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22262600      PMCID: PMC3674852          DOI: 10.1002/pds.2317

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  21 in total

1.  Is warfarin underused in the treatment of elderly persons with atrial fibrillation?

Authors:  J Whittle; L Wickenheiser; L N Venditti
Journal:  Arch Intern Med       Date:  1997-02-24

2.  Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation.

Authors:  M R Antani; R J Beyth; K E Covinsky; P A Anderson; D G Miller; R D Cebul; L M Quinn; C S Landefeld
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

3.  Warfarin use among patients with atrial fibrillation.

Authors:  L M Brass; H M Krumholz; J M Scinto; M Radford
Journal:  Stroke       Date:  1997-12       Impact factor: 7.914

4.  Atrial fibrillation as a risk factor for stroke: a retrospective cohort study of hospitalized Medicare beneficiaries.

Authors:  Z Yuan; S Bowlin; D Einstadter; R D Cebul; A R Conners; A A Rimm
Journal:  Am J Public Health       Date:  1998-03       Impact factor: 9.308

5.  Identifying hypertension-related comorbidities from administrative data: what's the optimal approach?

Authors:  Ann M Borzecki; Ashley T Wong; Elaine C Hickey; Arlene S Ash; Dan R Berlowitz
Journal:  Am J Med Qual       Date:  2004 Sep-Oct       Impact factor: 1.852

6.  Atrial fibrillation: prevalence after minimally invasive direct and standard coronary artery bypass.

Authors:  M Hravnak; L A Hoffman; M I Saul; T G Zullo; J F Cuneo; G R Whitman; J M Clochesy; B P Griffith
Journal:  Ann Thorac Surg       Date:  2001-05       Impact factor: 4.330

7.  Incidence of and risk factors for atrial fibrillation in older adults.

Authors:  B M Psaty; T A Manolio; L H Kuller; R A Kronmal; M Cushman; L P Fried; R White; C D Furberg; P M Rautaharju
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

8.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.

Authors:  W B Kannel; P A Wolf; E J Benjamin; D Levy
Journal:  Am J Cardiol       Date:  1998-10-16       Impact factor: 2.778

9.  Anticoagulant use for atrial fibrillation in the elderly.

Authors:  Mary T Brophy; Kerri E Snyder; Stephan Gaehde; Charlene Ives; David Gagnon; Louis D Fiore
Journal:  J Am Geriatr Soc       Date:  2004-07       Impact factor: 5.562

10.  Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation.

Authors:  G C Flaker; D J McGowan; M Boechler; G Fortune; B Gage
Journal:  Am Heart J       Date:  1999-02       Impact factor: 4.749

View more
  136 in total

1.  Practice Patterns and Outcomes of Treatments for Atrial Fibrillation During Sepsis: A Propensity-Matched Cohort Study.

Authors:  Allan J Walkey; Stephen R Evans; Michael R Winter; Emelia J Benjamin
Journal:  Chest       Date:  2016-01-06       Impact factor: 9.410

2.  PheValuator: Development and evaluation of a phenotype algorithm evaluator.

Authors:  Joel N Swerdel; George Hripcsak; Patrick B Ryan
Journal:  J Biomed Inform       Date:  2019-07-29       Impact factor: 6.317

3.  Electrocardiographic left atrial abnormality and stroke subtype in the atherosclerosis risk in communities study.

Authors:  Hooman Kamel; Wesley T O'Neal; Peter M Okin; Laura R Loehr; Alvaro Alonso; Elsayed Z Soliman
Journal:  Ann Neurol       Date:  2015-08-31       Impact factor: 10.422

4.  Effect of race on outcomes (stroke and death) in patients >65 years with atrial fibrillation.

Authors:  Rajesh Kabra; Peter Cram; Saket Girotra; Mary Vaughan Sarrazin
Journal:  Am J Cardiol       Date:  2015-04-16       Impact factor: 2.778

5.  Blood Pressure and Incident Atrial Fibrillation in Older Patients Initiating Hemodialysis.

Authors:  Tara I-Hsin Chang; Sai Liu; Medha Airy; Jingbo Niu; Mintu P Turakhia; Jennifer E Flythe; Maria E Montez-Rath; Wolfgang C Winkelmayer
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-07       Impact factor: 8.237

6.  Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation.

Authors:  Prashant D Bhave; Xin Lu; Saket Girotra; Hooman Kamel; Mary S Vaughan Sarrazin
Journal:  Heart Rhythm       Date:  2015-03-23       Impact factor: 6.343

7.  Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the Look AHEAD randomized trial.

Authors:  Alvaro Alonso; Judy L Bahnson; Sarah A Gaussoin; Alain G Bertoni; Karen C Johnson; Cora E Lewis; Marion Vetter; Christos S Mantzoros; Robert W Jeffery; Elsayed Z Soliman
Journal:  Am Heart J       Date:  2015-07-26       Impact factor: 4.749

8.  Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Elsayed Z Soliman; Faye Lopez; Wesley T O'Neal; Lin Y Chen; Lindsay Bengtson; Zhu-Ming Zhang; Laura Loehr; Mary Cushman; Alvaro Alonso
Journal:  Circulation       Date:  2015-04-27       Impact factor: 29.690

9.  Incidence of Atrial Fibrillation in Patients With Recent Ischemic Stroke Versus Matched Controls.

Authors:  Jens Witsch; Alexander E Merkler; Monica Lin Chen; Babak B Navi; Kevin N Sheth; Ben Freedman; Lee H Schwamm; Hooman Kamel
Journal:  Stroke       Date:  2018-10       Impact factor: 7.914

10.  Impact of atrial fibrillation on patients hospitalized for acute myocarditis: Insights from a nationally-representative United States cohort.

Authors:  Ahmed Subahi; Emmanuel Akintoye; Ahmed S Yassin; Hossam Abubakar; Oluwole Adegbala; Tushar Mishra; Mohamed Abdelrahman; Mohamed Shokr; Luis Afonso
Journal:  Clin Cardiol       Date:  2019-01-03       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.